518 related articles for article (PubMed ID: 10734179)
1. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR
J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
Gehlert DR; Schober DA; Beavers L; Gadski R; Hoffman JA; Smiley DL; Chance RE; Lundell I; Larhammar D
Mol Pharmacol; 1996 Jul; 50(1):112-8. PubMed ID: 8700103
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological evaluation of 1229U91, a novel high-affinity and selective neuropeptide Y-Y1 receptor antagonist.
Hegde SS; Bonhaus DW; Stanley W; Eglen RM; Moy TM; Loeb M; Shetty SG; DeSouza A; Krstenansky J
J Pharmacol Exp Ther; 1995 Dec; 275(3):1261-6. PubMed ID: 8531090
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
[TBL] [Abstract][Full Text] [Related]
5. The neuropeptide Y Y1 antagonist, 1229U91, a potent agonist for the human pancreatic polypeptide-preferring (NPY Y4) receptor.
Schober DA; Van Abbema AM; Smiley DL; Bruns RF; Gehlert DR
Peptides; 1998; 19(3):537-42. PubMed ID: 9533642
[TBL] [Abstract][Full Text] [Related]
6. Potent neuropeptide Y Y1 receptor antagonist, 1229U91: blockade of neuropeptide Y-induced and physiological food intake.
Kanatani A; Ishihara A; Asahi S; Tanaka T; Ozaki S; Ihara M
Endocrinology; 1996 Aug; 137(8):3177-82. PubMed ID: 8754736
[TBL] [Abstract][Full Text] [Related]
7. Evidence that stimulation of two modalities of pituitary luteinizing hormone release in ovarian steroid-primed ovariectomized rats may involve neuropeptide Y Y1 and Y4 receptors.
Jain MR; Pu S; Kalra PS; Kalra SP
Endocrinology; 1999 Nov; 140(11):5171-7. PubMed ID: 10537146
[TBL] [Abstract][Full Text] [Related]
8. The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability.
Kanatani A; Kanno T; Ishihara A; Hata M; Sakuraba A; Tanaka T; Tsuchiya Y; Mase T; Fukuroda T; Fukami T; Ihara M
Biochem Biophys Res Commun; 1999 Dec; 266(1):88-91. PubMed ID: 10581170
[TBL] [Abstract][Full Text] [Related]
9. Functional and molecular properties of the human recombinant Y4 receptor: resistance to agonist-promoted desensitization.
Voisin T; Goumain M; Lorinet AM; Maoret JJ; Laburthe M
J Pharmacol Exp Ther; 2000 Feb; 292(2):638-46. PubMed ID: 10640301
[TBL] [Abstract][Full Text] [Related]
10. Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5).
Dumont Y; Cadieux A; Doods H; Fournier A; Quirion R
Can J Physiol Pharmacol; 2000 Feb; 78(2):116-25. PubMed ID: 10737674
[TBL] [Abstract][Full Text] [Related]
11. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
Umeda T; Kanatani A; Iwaasa H
Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the cloned atlantic cod neuropeptide Y-Yb receptor: peptide-binding requirements distinct from known mammalian Y receptors.
Sharma P; Arvidsson AK; Wraith A; Beck-Sickinger AG; Jönsson-Rylander AC; Larhammar D
Gen Comp Endocrinol; 1999 Sep; 115(3):422-8. PubMed ID: 10480994
[TBL] [Abstract][Full Text] [Related]
13. Characterization of G protein and phospholipase C-coupled agonist binding to the Y1 neuropeptide Y receptor in rat brain: sensitivity to G protein activators and inhibitors and to inhibitors of phospholipase C.
Parker SL; Parker MS; Sweatman T; Crowley WR
J Pharmacol Exp Ther; 1998 Jul; 286(1):382-91. PubMed ID: 9655883
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y as a partial agonist of the Y1 receptor.
Sah R; Balasubramaniam A; Parker MS; Sallee F; Parker SL
Eur J Pharmacol; 2005 Nov; 525(1-3):60-8. PubMed ID: 16293244
[TBL] [Abstract][Full Text] [Related]
15. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon.
Goumain M; Voisin T; Lorinet AM; Laburthe M
Biochem Biophys Res Commun; 1998 Jun; 247(1):52-6. PubMed ID: 9636652
[TBL] [Abstract][Full Text] [Related]
16. Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.
Wieland HA; Willim KD; Entzeroth M; Wienen W; Rudolf K; Eberlein W; Engel W; Doods HN
J Pharmacol Exp Ther; 1995 Oct; 275(1):143-9. PubMed ID: 7562543
[TBL] [Abstract][Full Text] [Related]
17. Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains.
Dumont Y; Jacques D; Bouchard P; Quirion R
J Comp Neurol; 1998 Dec; 402(3):372-84. PubMed ID: 9853905
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the existence of an additional class of neuropeptide Y receptor sites in rat brain.
Dumont Y; Moyse E; Fournier A; Quirion R
J Pharmacol Exp Ther; 2005 Oct; 315(1):99-108. PubMed ID: 15947033
[TBL] [Abstract][Full Text] [Related]
19. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
Iyengar S; Li DL; Simmons RM
J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
[TBL] [Abstract][Full Text] [Related]
20. Expression cloning of a human brain neuropeptide Y Y2 receptor.
Gehlert DR; Beavers LS; Johnson D; Gackenheimer SL; Schober DA; Gadski RA
Mol Pharmacol; 1996 Feb; 49(2):224-8. PubMed ID: 8632753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
